Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Enoxaparin sodium/epinephrine/ethiodized oil Ventricular dysrhythmia, intraparenchymal hemorrhage and embolic cerebral infarction: 5 case reportsIn a retrospective, observational study of 9 boys with single-ventricle congenital heart disease (CHD) admitted to hospital between 1 January 2005 and 31 December 2019, 5 boys (aged 4.3-17.3 years) were described, who developed ventricular dysrhythmia, intraparenchymal haemorrhage (IPH) or embolic cerebral infarction during treatment with enoxaparin sodium, epinephrine or ethiodized oil [not all routes and outcomes stated; dosages and times to reactions onsets not stated].The 17.3-year-old boy (case C), who had single-ventricle CHD, had double inlet left ventricle and hypoplastic right ventricle status-post Glenn and Fontan procedure. He was involved in an motor vehicle accident, leading to traumatic brain injury, and hospitalised. On presentation, he was intubated, and mechanical ventilator support was started. Subarachnoid haemorrhage, intraventricular haemorrhage, diffuse axonal injury and bilateral intraparenchymal haematomas were detected. He had intracranial hypertension and low cerebral perfusion pressure; therefore, he started receiving unspecified sedation and neuromuscular blockade, sodium chloride [hypertonic saline] and mild hyperventilation. During the initial 2 days, he required high positive endexpiratory pressure (PEEP) and mean airway pressure (MAWP) for the management of atelectasis and hypoxaemia and due to the concern for aspiration pneumonia. Also, he required dopamine, epinephrine infusion and phenylephrine on post-CNS injury day 1, which were escalated immediately due to haemodynamic instability. Subsequently, he improved, and the epinephrine infusion was weaned and discontinued. However, on post-CNS injury day 6, he experienced worsening atelectasis and hypoxic episodes, requiring an increase in PEEP. This contributed to an increase in MAWP also. Therefore, he started receiving epinephrine infusion, which led to ventricular dysrhythmias. He therefore required treatment with lidocaine. Subsequently, his haemodynamic, neurological and respiratory status continued to improve, and vasoactive and lidocaine infusions were weaned off. He was extubated successfully on post-CNS injury day 26. However, 2 days later, he developed hypotension associated with worsening echocardiographic myocardial dysfunction in addition to significant arrhythmias. He developed a fatal cardiac arrest [aetiology unknown] on day 34.The 4.3-year-old boy (case D), who had single-ventricle CHD, had hypoplastic left heart syndrome status-post Glenn procedure, and he had been receiving milrinone due to worsening heart failure. He had been chronically receiving anticoagulation treatment with enoxaparin sodium [Lovenox]. He was hospitalised with Candida fungaemia and septic shock, due to which he developed disseminated intravascular coagulopathy (DIC). Radiologically, left frontal IPH and intraventricular haemorrhage with hydrocephalus. The IPH was considered to have been caused due to...
Enoxaparin sodium/epinephrine/ethiodized oil Ventricular dysrhythmia, intraparenchymal hemorrhage and embolic cerebral infarction: 5 case reportsIn a retrospective, observational study of 9 boys with single-ventricle congenital heart disease (CHD) admitted to hospital between 1 January 2005 and 31 December 2019, 5 boys (aged 4.3-17.3 years) were described, who developed ventricular dysrhythmia, intraparenchymal haemorrhage (IPH) or embolic cerebral infarction during treatment with enoxaparin sodium, epinephrine or ethiodized oil [not all routes and outcomes stated; dosages and times to reactions onsets not stated].The 17.3-year-old boy (case C), who had single-ventricle CHD, had double inlet left ventricle and hypoplastic right ventricle status-post Glenn and Fontan procedure. He was involved in an motor vehicle accident, leading to traumatic brain injury, and hospitalised. On presentation, he was intubated, and mechanical ventilator support was started. Subarachnoid haemorrhage, intraventricular haemorrhage, diffuse axonal injury and bilateral intraparenchymal haematomas were detected. He had intracranial hypertension and low cerebral perfusion pressure; therefore, he started receiving unspecified sedation and neuromuscular blockade, sodium chloride [hypertonic saline] and mild hyperventilation. During the initial 2 days, he required high positive endexpiratory pressure (PEEP) and mean airway pressure (MAWP) for the management of atelectasis and hypoxaemia and due to the concern for aspiration pneumonia. Also, he required dopamine, epinephrine infusion and phenylephrine on post-CNS injury day 1, which were escalated immediately due to haemodynamic instability. Subsequently, he improved, and the epinephrine infusion was weaned and discontinued. However, on post-CNS injury day 6, he experienced worsening atelectasis and hypoxic episodes, requiring an increase in PEEP. This contributed to an increase in MAWP also. Therefore, he started receiving epinephrine infusion, which led to ventricular dysrhythmias. He therefore required treatment with lidocaine. Subsequently, his haemodynamic, neurological and respiratory status continued to improve, and vasoactive and lidocaine infusions were weaned off. He was extubated successfully on post-CNS injury day 26. However, 2 days later, he developed hypotension associated with worsening echocardiographic myocardial dysfunction in addition to significant arrhythmias. He developed a fatal cardiac arrest [aetiology unknown] on day 34.The 4.3-year-old boy (case D), who had single-ventricle CHD, had hypoplastic left heart syndrome status-post Glenn procedure, and he had been receiving milrinone due to worsening heart failure. He had been chronically receiving anticoagulation treatment with enoxaparin sodium [Lovenox]. He was hospitalised with Candida fungaemia and septic shock, due to which he developed disseminated intravascular coagulopathy (DIC). Radiologically, left frontal IPH and intraventricular haemorrhage with hydrocephalus. The IPH was considered to have been caused due to...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.